Submit Deal

AKERO THERAPEUTICS

HQ - South San Francisco, California

Summary

Akero Therapeutics, a U.S. clinical-stage biotech focused on metabolic liver disease.

Deals Overview

Total Deals1

Valued Deals1

Total Value£ 3.51 B

Avg. Deal Size£ 3.51 B

Market Context

Sort

jp morgan

HQ - New York

financial advisors (1)

1 Shared Deal

1 For

£ 3.51 B

Total Value

brunswick group

HQ - London, United Kingdom

pr advisors (1)

1 Shared Deal

1 Opposite

£ 3.51 B

Total Value

bank of america

HQ - Charlotte

financial advisors (1)

1 Shared Deal

1 Opposite

£ 3.51 B

Total Value

ropes & gray

HQ - Boston

legal advisors (1)

1 Shared Deal

1 Opposite

£ 3.51 B

Total Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy